US Stock MarketDetailed Quotes
SYRS Syros Pharmaceuticals
- 0.2684
- -0.0248-8.46%
Trading Nov 25 11:25 ET
7.20MMarket Cap-87P/E (TTM)
0.2989High0.2601Low2.79MVolume0.2989Open0.2932Pre Close757.88KTurnover17.65%Turnover RatioLossP/E (Static)26.83MShares8.170052wk High-0.65P/B4.25MFloat Cap0.183052wk Low--Dividend TTM15.83MShs Float243.7500Historical High--Div YieldTTM13.23%Amplitude0.1830Historical Low0.2710Avg Price1Lot Size
About Syros Pharmaceuticals Company
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Company Profile
SymbolSYRS
Company NameSyros Pharmaceuticals
Listing DateJun 30, 2016
Issue Price12.50
Founded2011
CEOMr. Gerald E. Quirk
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address35 CambridgePark Drive,4th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02140-2325
Phone1-617-744-1340
Websitehttp://www.syros.com
Company Executives
- Name
- Position
- Salary
- Gerald E. Quirk
- President and Chief Executive Officer
- --
- Kristin Stephens
- Chief Development Officer
- --
- Peter Wirth, J.D.
- Chairman of the Board
- 110.40K
- Dr. Nancy A. Simonian,M.D.
- Director
- 1.44M
- Marsha H. Fanucci
- Independent Director
- 84.78K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
